Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

421.04 +2.46 (+0.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 446,666
Open 420.63
Bid (Size) 420.70 (2)
Ask (Size) 421.17 (1)
Prev. Close 418.58
Today's Range 411.92 - 422.39
52wk Range 266.98 - 459.48
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
If You Invested $100 In United Therapeutics Stock 15 Years Ago, You Would Have This Much Today
 
Via Benzinga
United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge
In a financial landscape often fixated on consistent dividend payouts, United Therapeutics Corporation (NASDAQ: UTHR) stands out with a distinct capital allocation strategy. Contrary to market... 
Via MarketMinute
Topics Retirement

Performance

YTD
+16.9%
+16.9%
1 Month
-2.7%
-2.7%
3 Month
+41.2%
+41.2%
6 Month
+41.7%
+41.7%
1 Year
+20.4%
+20.4%

More News

Read More
United Therapeutics Corp (NASDAQ:UTHR) Meets Key Peter Lynch Investment Criteria
Via Chartmill
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
From United Therapeutics Corporation
Via Business Wire
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results
Via Stocktwits
This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside
Via Stocktwits
United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Prime Value Investment Candidate
Via Chartmill
1 Value Stock for Long-Term Investors and 2 Facing Headwinds
Via StockStory
United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting
From United Therapeutics Corporation
Via Business Wire
2 Growth Stocks with All-Star Potential and 1 Facing Headwinds
Via StockStory
This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis
From United Therapeutics Corporation
Via Business Wire
1 Momentum Stock to Target This Week and 2 We Brush Off
Via StockStory
3 Big Reasons to Love United Therapeutics (UTHR)
Via StockStory
Topics Stocks
United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Top Peter Lynch-Style GARP Investment
Via Chartmill
United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
From United Therapeutics Corporation
Via Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
Via Investor's Business Daily
Topics ETFs
Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio?
Via Benzinga
United Therapeutics Corp (NASDAQ:UTHR): A Prime Value Investing Candidate with Strong Fundamentals
Via Chartmill
Here are the top movers in Tuesday's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Results
Via Benzinga
Topics Stocks
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
Via Chartmill
Why Is United Therapeutics Stock Rallying On Tuesday?
Via Benzinga

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 421.04
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 10/27/25 04:00 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 18.90B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.